We have also examined 3 additional cancer markers, the proliferating cell nuclear antigen, epidermal growth factor receptor, and Vimentin, which all confirmed that the LF-RMFs could inhibit the breast cancer metastasis in lung tissues, and the 0.4-T LF-RMF had a more significant effect than the 0.1-T LF-RMF (Fig. S13). This evidence concerns the gene VIM and breast carcinoma.